Senior Staff Oncologist, Division of Hematology and Oncology;
Director, Cancer Genetics Program;
Senior Scientist, Genetics and Genome Biology,
Toronto, Ontario, Canada
For his unrivaled, visionary, and paradigm-shifting holistic approaches to treating pediatric cancer, for discovering the link between germline mutations in the TP53 tumor suppressor gene and the Li-Fraumeni cancer susceptibility syndrome and establishing the “Toronto protocol” for tumor surveillance in Li-Fraumeni Syndrome. He initiated the first childhood cancer predisposition clinic, which has served as the gold-standard for the management of families with cancer predisposition syndromes, while spearheading cancer genomic efforts including sophisticated diagnostic, prognostic, and surveillance tools for the management of such patients.
The AACR-St. Baldrick’s Foundation Award for Outstanding Achievement in Pediatric Cancer Research was established in 2019 to recognize major research discoveries in pediatric cancer research and to honor an individual who has significantly contributed to any area of pediatric cancer research, resulting in the fundamental improvement of the understanding and/or treatment of pediatric cancer. Uniquely, the award recipient is also afforded the opportunity to nominate junior faculty at the assistant professor level or equivalent, who are affiliated with an academic institution involved in cancer research, cancer medicine, or cancer-related sciences, to be considered to receive a one-year, $75,000 AACR-St. Baldrick’s Foundation Pediatric Cancer Research Fellowship.
To learn more, please visit the press release.